Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorDamanhour Teaching Hospital

About this trial

Background: Although thoracoscopic sympathectomy is made via small incisions, it is associated with severe postoperative pain. Both Rhomboid intercostal block (RIB) and Retrolaminar block (RLB) are recent techniques used for pain control after such procedures

Objectives: To compare the effectiveness of RIB and RLB in providing postoperative analgesia after thoracoscopic sympathectomy in adult patients and their impact on the patient's outcomes.

Patients and Methods: This prospective, randomized (1:1), double-blind clinical trial; will be carried out on 60 patients scheduled for elective thoracoscopic sympathectomy under general anesthesia at our hospital. Patients will be randomly allocated into two equal groups (30 patients each) and will receive: in group A; general anesthesia with intraoperative ipsilateral ultrasound-guided RIB, whereas in group B; general anesthesia with intraoperative ipsilateral ultrasound-guided RLB.

Eligibility criteria

Qualifiers

American Society of Anesthesiologists (ASA) physical status ≤ II

Age from 18 to 60 years

Body Mass Index (BMI) < 35 kg/m²

Disqualifiers

American Society of Anesthesiologists (ASA) physical status > II

Age < 18 years or > 60 years

Body Mass Index (BMI) ≥ 35

Local infection at the puncture site

Trial design

Treatments tested in this trial

  • Rhomboid Intercostal Block (RIB)
  • Retrolaminar Block (RLB)

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators